Clinical trial
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients…
NCT00476099 · Chiesi Farmaceutici S.p.A., Industry · Completed
Key facts
| NCT number | NCT00476099 |
|---|---|
| Title | Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD |
| Official title | A 48-week, Double Blind, Double Dummy, Randomised, Multinational, Multicentre, 3-arm Parallel Group Clinical Study of "Fixed Combination" Beclometasone Dipropionate Plus Formoterol Fumarate Administered Via pMDI With HFA-134a Propellant Versus "Fixed Combination" Budesonide Plus Formoterol DPI… |
| Lead sponsor | Chiesi Farmaceutici S.p.A., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI, Budesonide 200 µg plus formoterol 6 µg DPI, Formoterol 12 µg DPI |
| Enrollment | 828 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 21, 2007 |
| Last update posted | Oct 29, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: